Skip to main content

17 Result(s)

within Navneet S. Majhail Remove this filter Public Health Remove this filter

and

  1. No Access

    Article

    International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update

    As hematopoietic cell transplantation (HCT) and cellular therapy expand to new indications and international access improves, the volume of HCT performed annually continues to rise. Parallel improvements in HC...

    Seth J. Rotz, Neel S. Bhatt, Betty K. Hamilton… in Bone Marrow Transplantation (2024)

  2. No Access

    Article

    The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma

    Recently there has been a growing interest in evaluating body composition as a marker for prognosis in cancer patients. The association of body composition parameters and outcomes has not been deeply investiga...

    Gabriel F. P. Aleixo, Wei Wei, Po-Hao Chen, Namita S. Gandhi… in Bone Marrow Transplantation (2023)

  3. No Access

    Article

    Resource utilization in patients with large B-cell lymphoma receiving tisagenlecleucel and axicabtagene ciloleucel

    Agrima Mian, Wei Wei, Betty K. Hamilton, Allison M. Winter… in Bone Marrow Transplantation (2023)

  4. No Access

    Article

    Pattern of somatic mutation changes after allogeneic hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes

    Sanghee Hong, Lisa Rybicki, Carmelo Gurnari, Simona Pagliuca… in Bone Marrow Transplantation (2022)

  5. No Access

    Article

    Evaluation of pre-transplant risk assessments in allogeneic hematopoietic cell transplant

    Pranay S. Hegde, Lisa Rybicki, Sheila Serafino… in Bone Marrow Transplantation (2022)

  6. No Access

    Article

    Community health status and long-term outcomes in 1-year survivors of autologous and allogeneic hematopoietic cell transplantation

    Julia H. Joo, Sanghee Hong, Lisa A. Rybicki… in Bone Marrow Transplantation (2022)

  7. No Access

    Article

    Day 100 risk assessment tool predicts overall survival in allogeneic hematopoietic cell transplantation

    Pranay Hegde, Lisa Rybicki, Sheila Serafino… in Bone Marrow Transplantation (2022)

  8. No Access

    Article

    To D or not to D: vitamin D in hematopoietic cell transplantation

    Vitamin D plays an essential role in bone health, immune tolerance, and immune modulation. Autologous and allogeneic hematopoietic cell transplantation (HCT) recipients are at increased risk of vitamin D defic...

    Sanghee Hong, Christina S. Ferraro, Betty K. Hamilton… in Bone Marrow Transplantation (2020)

  9. No Access

    Article

    Patient-reported outcomes in acute graft-versus-host disease: optimizing patient care and clinical trial endpoints

    Patient-reported outcomes (PROs) refer to patient perceived and reported health-related quality of life (HRQOL), functional status, and symptom burden. PROs have become an important measure in oncologic care t...

    Sagar S. Patel, Brittany Lapin, Navneet S. Majhail… in Bone Marrow Transplantation (2020)

  10. No Access

    Article

    Healthcare Costs of Treating Privately Insured Patients with Acute Myeloid Leukemia in the United States from 2004 to 2014: A Generalized Additive Modeling Approach

    The primary objective of this study was to predict healthcare cost trajectories for patients with newly diagnosed acute myeloid leukemia (AML) receiving allogeneic hematopoietic cell transplantation (alloHCT),...

    Lih-Wen Mau, Jaime M. Preussler, Linda J. Burns, Susan Leppke… in PharmacoEconomics (2020)

  11. No Access

    Article

    Transplant center characteristics and survival after allogeneic hematopoietic cell transplantation in adults

    Allogeneic hematopoietic cell transplantation (alloHCT) is a highly specialized procedure. We surveyed adult transplant centers in the United States (US) and then used data reported to the Center for Internati...

    Navneet S. Majhail, Lih-Wen Mau, Pintip Chitphakdithai… in Bone Marrow Transplantation (2020)

  12. No Access

    Article

    BEAM or BUCYVP16-conditioning regimen for autologous stem-cell transplantation in non-Hodgkin’s lymphomas

    High-dose chemotherapy followed by autologous hematopoietic cell transplantation (AHCT) is an effective salvage therapy for patients with relapsed chemosensitive non-Hodgkin’s lymphoma (NHL). However, the opti...

    Sara Singer, Nidhi Sharma, Robert Dean, Qiuhong Zhao… in Bone Marrow Transplantation (2019)

  13. No Access

    Article

    Psychosocial Assessment of Candidates for Transplant (PACT) as a tool for psychological and social evaluation of allogeneic hematopoietic cell transplantation recipients

    Psychosocial Assessment of Candidates for Transplant (PACT) is a tool originally developed to address psychosocial risks in solid organ transplant recipients and has the potential for application to hematopoie...

    Sanghee Hong, Lisa Rybicki, Donna Corrigan, Jane Dabney… in Bone Marrow Transplantation (2019)

  14. No Access

    Article

    Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes

    Next generation sequencing (NGS) has become an important tool to inform disease risk for myeloid malignancies, however data remains conflicting regarding the significance of individual mutations. We performed ...

    Betty K. Hamilton, Lisa Rybicki, Casandra Hirsch… in Bone Marrow Transplantation (2019)

  15. No Access

    Article

    Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation

    Donor-derived T-cells mediate graft-versus-leukemia effect, immune reconstitution, and graft-versus-host-disease (GvHD) after allogeneic hematopoietic cell transplantation (HCT). We examined the association of...

    Sagar S. Patel, Lisa A. Rybicki, Donna Corrigan… in Bone Marrow Transplantation (2019)

  16. No Access

    Article

    Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation

    We analyzed late cardiovascular outcomes of 661 patients who survived at least 2 years from hematopoietic cell transplantation for childhood hematologic malignancy between 1995 and 2008. Center for Internation...

    Christine N. Duncan, Ruta Brazauskas, Jiaxing Huang… in Bone Marrow Transplantation (2018)

  17. No Access

    Article

    Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial

    Sleep disruption has received little attention in hematopoietic cell transplantation (HCT). The goal of this study was to describe severity, course, and predictors of sleep disruption following HCT. A secondar...

    Heather S. L. Jim, Steven Sutton, Navneet S. Majhail… in Bone Marrow Transplantation (2018)